Total Neoadjuvant Therapy in Rectal Cancer in the Community Setting | 2022 Evolution Conference

แชร์
ฝัง
  • เผยแพร่เมื่อ 14 ม.ค. 2025

ความคิดเห็น • 4

  • @khaliddurrani6432
    @khaliddurrani6432 2 ปีที่แล้ว +2

    To conclude for T,2,3 rectal tumors short course radiation is appropriate as in RAPIDO trial, but for stage 3 or T4 tumors long course CRt is preferred. In either case surgery is performed 8-10 weeks after the last dose of radiation and chemo is given peri-operatively. TNT implies chemo radiation and 3months of chemo prior to TME. OPRA trial shows slight advantage of chemo ( consolidation) after radiation rather than before (induction chemo).

  • @michaels908
    @michaels908 11 หลายเดือนก่อน

    I'm starting immunotherapy with Keytruda beginning on March 4th. I have stage 4 rectal cancer, with a miss-matched mutant tumors. Eighteen patients were involved in a clinical trial at Memorial Sloan Kettering Cancer Center one year ago and they had a 100% success rate. All their tumors vanished. What better odds can I get.

    • @davidgardner1675
      @davidgardner1675 9 หลายเดือนก่อน

      This your LIFE make it happen